Jon R. Levine - 29 May 2026 Form 4 Insider Report for MARIMED INC. (MRMD)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
02 Jun 2026, 16:12:34 UTC
Prior SEC filing
26 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Jon R. Levine

Key filing fact

Jon R. Levine filed Form 4 for MARIMED INC. (MRMD) on 02 Jun 2026.

Key facts

  • This page summarizes Jon R. Levine's Form 4 filing for MARIMED INC. (MRMD).
  • 3 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 02 Jun 2026, 16:12.

Change

  • Previous filing in this sequence was filed on 26 May 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001789645 Primary reporting owner

Levine Jon R

Relationship
President and CEO, Director, 10%+ Owner
Address
C/O MARIMED INC., 10 OCEANA WAY, NORWOOD,
Signature
/s/ Jon R. Levine
Signature date
01 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRMD transaction

Common stock

Options Exercise

Transaction value
Shares
+46,875
Change %
+0.22%
Price
$0.000000*
Shares after
21,354,861
Date
29 May 2026
Ownership
Direct
Footnotes
F1
MRMD transaction

Common stock

Tax liability

Transaction value
Shares
-16,243
Change %
-0.08%
Price
$0.0805*
Shares after
21,338,618
Date
29 May 2026
Ownership
Direct
Footnotes
F2
MRMD holding

Common stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,684,640
Date
29 May 2026
Ownership
By the Jon Levine Family Trust
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MRMD transaction Derivative

Restricted Stock Units (RSU)

Options Exercise

Transaction value
Shares
-46,875
Change %
-25%
Price
$0.000000*
Shares after
140,625
Date
29 May 2026
Ownership
Direct
Underlying class
Common Stock, par value $.001 per share
Underlying amount
46,875
Exercise price
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

RSUs convert to shares of common stock on a one-for-one basis.

Footnote F2

Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

Footnote F3

These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F4

The RSUs were granted on November 29, 2024; the remaining RSUs under this grant will vest in three equal installments on each of November 29, 2026, May 29, 2027 and November 29, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .